drugset / Trial / NCT04899687
Study of Dextromethorphan in OCD and Related Disorders
RandomizedCrossoverSingle-blindTreatment
Summary
The purpose of the study is to assess the tolerability and efficacy of dextromethorphan in combination with fluoxetine for symptom relief in OCD and related disorders.
Timeline
- Start
- 2022-01-20
- Primary completion
- 2027-04-01
- Completion
- 2028-12-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dextromethorphan | Unknown | 60 mg | Oral |
| Background | Fluoxetine | Small molecule | 20 mg | Oral |